BioQ Pharma is a San Francisco, CA-based specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceutical and biological products for rapid deployment at the point of care. The company is ISO13485 certified and maintains commercial collaborations and strategic partnerships with organizations including Novartis’ Sandoz unit, Cipla, Lee’s Pharm, Lunatus, Galen Limited, Pharma Mart, and West Pharmaceutical Services. Led by CEO Josh Krisel, BioQ has commercial operations that it intends to expand with new financing. It plans to use proceeds to support anticipated near-term regulatory approvals and to advance earlier-stage development activities. The company secured new financing of up to $55M from Madryn Asset Management, LP to support those initiatives.

Total raised

$55M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2017